Cellectis
CLLS
#7743
Rank
ยฃ0.26 B
Marketcap
ยฃ2.58
Share price
-1.13%
Change (1 day)
101.40%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: ยฃ0.26 Billion

As of February 2026 Cellectis has a market cap of ยฃ0.26 Billion. This makes Cellectis the world's 7743th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ0.26 B-25.61%
2025ยฃ0.35 B208.71%
2024ยฃ0.11 B-33.77%
2023ยฃ0.17 B113.94%
2022ยฃ80.89 M-71.5%
2021ยฃ0.28 B-69.66%
2020ยฃ0.93 B64.45%
2019ยฃ0.56 B-1.35%
2018ยฃ0.57 B-22.68%
2017ยฃ0.74 B51.98%
2016ยฃ0.49 B-32.28%
2015ยฃ0.72 B157.61%
2014ยฃ0.28 B592.94%
2013ยฃ40.59 M

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Cellectis was reported to be:

ยฃ0.18 Billion
by Nasdaq info icon info icon
ยฃ0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
ยฃ59.67 B 22,571.51%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
ยฃ1.12 B 327.26%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
ยฃ0.94 B 257.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
ยฃ0.33 B 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA